Cipla (CIPLA) — Corporate Action

Cipla Limited allotted 5,518 fully paid-up equity shares of ₹2 face value each on October 29, 2025, following employee stock option and stock appreciation rights exercises under the ESOS 2013-A and ESAR 2021 schemes. The company's issued and paid-up capital increased to ₹1,61,55,42,426, comprising 80,77,71,213 equity shares. This represents a minimal dilution of approximately 0.007% to existing shareholders.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CIPLA ✨ Ask AI About This

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,15,682.55 Cr P/E: 25.4 ROE: 14.6% ROCE: 19.4%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

💡 Ask AI about this filing

"How does this corporate action affect Cipla Limited's outlook?" "What did Cipla Limited announce on 29 October 2025?" "Is this positive or negative for CIPLA?"

Ask AI Free →

📊 More CIPLA filings

See all CIPLA filings →

🔥 Also filed on 29 October 2025

TATASTEEL Tata Steel Limited Announcement TITAN Titan Company Limited Announcement VBL Varun Beverages Limited Financial Results VBL Varun Beverages Limited Financial Results VBL Varun Beverages Limited Financial Results TATASTEEL Tata Steel Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.